Follow
Aline Hunger
Aline Hunger
FMUSP
Verified email at usp.br
Title
Cited by
Cited by
Year
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
RFV Medrano, A Hunger, SA Mendonça, JAM Barbuto, BE Strauss
Oncotarget 8 (41), 71249, 2017
1742017
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
A Hunger, RFV Medrano, DB Zanatta, PR Del Valle, CA Merkel, TA Salles, ...
Cell Death Discovery 3 (1), 1-12, 2017
312017
Timp1 promotes cell survival by activating the PDK1 signaling pathway in melanoma
M Toricelli, FHM Melo, A Hunger, D Zanatta, BE Strauss, MG Jasiulionis
Cancers 9 (4), 37, 2017
292017
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy
RFV Medrano, JPP Catani, AH Ribeiro, SL Tomaz, CA Merkel, ...
Cancer Immunology, Immunotherapy 65, 371-382, 2016
262016
Intratumoral immunization by p19Arf and interferon-β gene transfer in a heterotopic mouse model of lung carcinoma
JPP Catani, RFV Medrano, A Hunger, P Del Valle, S Adjemian, ...
Translational Oncology 9 (6), 565-574, 2016
252016
Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector
RE Tamura, A Hunger, DC Fernandes, FR Laurindo, E Costanzi-Strauss, ...
Human gene therapy 28 (8), 639-653, 2017
222017
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
A Hunger, RFV Medrano, BE Strauss
Cell Death & Disease 8 (5), e2784, 2017
122017
Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death
RFV Medrano, A Hunger, JPP Catani, BE Strauss
Oncoimmunology 6 (7), e1329072, 2017
112017
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget. 2017; 8 (41): 71249–84
RFV Medrano, A Hunger, SA Mendonca, JAM Barbuto, BE Strauss
7
miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients
AT da Cruz, A Hunger, FHM de Melo, AC Monteiro, GC Pare, D Lai, ...
Neoplasia 23 (8), 823-834, 2021
62021
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget 8, 71249–71284
RFV Medrano, A Hunger, SA Mendonca, JAM Barbuto, BE Strauss
62017
Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death
PR Del Valle, SA Mendonça, F Antunes, A Hunger, RE Tamura, ...
Cancer Biology & Therapy 22 (4), 301-310, 2021
52021
Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector
TIP David, OLD Cerqueira, MG Lana, RFV Medrano, A Hunger, ...
Scientific Reports 10 (1), 17893, 2020
52020
Induction of Immune-Stimulating Factors and Oncolysis Upon p14ARF Gene Transfer in Melanoma Cell Lines
SA Mendonça, F Antunes, OLD Cerqueira, PR Del Valle, A Hunger, ...
DNA and Cell Biology 42 (6), 274-288, 2023
22023
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
RFV Medrano, TA Salles, R Dariolli, F Antunes, VA Feitosa, A Hunger, ...
Scientific Reports 12 (1), 13636, 2022
22022
Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf
IL Vieira, RE Tamura, A Hunger, BE Strauss
Journal of Interferon & Cytokine Research 39 (4), 246-258, 2019
22019
p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro
RC Da-Costa, IL Vieira, A Hunger, RE Tamura, BE Strauss
Brazilian Journal of Medical and Biological Research 53, e8876, 2020
12020
Abstract B134: Use of p19Arf/interferon-β immunotherapy in association with chemotherapy permits reduced drug dosage and avoids cardiotoxicity associated with doxorubicin
BE Strauss, RFV Medrano, R Tamura, SA Mendonça, VA Feitosa, ...
Cancer Immunology Research 7 (2_Supplement), B134-B134, 2019
2019
Circadian phase, chronotype and sleep-wake cycle under real-life conditions: the baependi heart study cohort
FS Ruiz, F Beijamini, B Gonçalves, B Middleton, JE Krieger, H Vallada, ...
Sleep Medicine, 2019
2019
Use of p19Arf/interferon-beta immunotherapy in association with chemotherapy permits reduced drug dosage and avoids cardiotoxicity associated with doxorubicin
BE Strauss, RFV Medrano, R Tamura, SA Mendonca, VA Feitosa, ...
Cancer Immunology Research, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20